This Biotech Stock Soared: Why One Fund Sold $3 Million
A biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
A quick beginner guide to selecting a SP 500 index fund for an IRA in 2024, covering costs, diversification, and what to look for in a starter fund.
23,805 articlesA biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
Louisiana approves a $3.3 billion tax incentive package for Meta's $10 billion Hyperion data center, intensifying a n...
Goldman Sachs argues that a rapid, AI-driven reordering of jobs remains unlikely. There’s little evidence of a broad ...
JPMorgan Chase CEO Jamie Dimon warns that markets may be riding an exuberant wave around AI and Big Tech, signaling ...
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Vistra's Q1 2026 results shed light on margin dynamics across generation, retail, and renewables. This guide breaks d...
Public blunders can impact more than pride—they can touch endorsements, streaming dollars, and future opportunities. ...
Michael Saylor rebutted critics of MicroStrategy's Bitcoin sales as BTC slides and the stock falters. He stressed the...
As inflation sticks around, a bigger 2027 social security COLA could boost retirees’ monthly payments. Yet economists...
A historic Knicks championship ends a 53-year wait and offers practical leadership and personal finance lessons on pa...
A new VA loan fee package moves through Congress, raising costs for refinances and assumptions. Industry groups warn ...
SpaceX captures headlines with bold tech and presumed multi-bagger upside. Still, the stock question isn’t simple. Th...